All the news Showing 10 of 156 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Testing for liver fibrosis & cirrhosis US doctors failing to diagnose hepatitis C years after first signs of cirrhosis Keith Alcorn / 23 August 2019 Doctors are failing to test for hepatitis C in up to one in five people who have advanced liver disease despite many years of medical care, and these people are more likely ... NAFLD NAFLD a rising cause of liver disease in people with HIV Liz Highleyman / 23 April 2019 Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious liver problems and liver-related death among people living with HIV in the ... Diabetes & HCV Hepatitis C treatment reduces risk of diabetes Liz Highleyman / 18 March 2019 Treatment of hepatitis C virus (HCV) infection is associated with better glucose control and a lower likelihood of developing diabetes, according to a report at the Conference on Retroviruses and Opportunistic Infections (CROI ... Sex between men Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up Liz Highleyman / 07 March 2019 New cases of hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men seen at three clinics in London have declined by nearly 70% since 2015, according to a presentation yesterday ... Diabetes Hepatitis C cure does not improve glucose control in type 2 diabetes Michael Carter / 07 February 2019 A successful response to hepatitis C virus (HCV) therapy does not result in long-term improvements in glucose metabolism for people with type 2 diabetes, according to US research published in Liver International. A sustained ... Hepatitis C elimination Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... Hepatocellular carcinoma (HCC) US FDA approves pembrolizumab immunotherapy for liver cancer Liz Highleyman / 12 November 2018 The US Food and Drug Administration last week granted accelerated approval for pembrolizumab (Keytruda), an immunotherapy drug known as a checkpoint inhibitor, for people with hepatocellular carcinoma (HCC). Over years or decades chronic hepatitis B ... Injecting drug use Majority of US young adults who use drugs are not tested for hepatitis C or HIV Liz Highleyman / 16 October 2018 Only about a third of adolescents and young adults diagnosed with opioid use disorder in the United States are screened for hepatitis C virus (HCV) or HIV, even though injection drug use is ... Screening policy All pregnant women in the United States should be screened for hepatitis C, say specialists Keith Alcorn / 20 September 2018 Hepatitis C specialists from several of the largest medical schools in the United States say that changes in the epidemiology of hepatitis C over the past decade make it essential to switch ... Screening and testing policy Little progress towards 'test all baby boomers for hepatitis C' since 2013, US study shows Keith Alcorn / 17 September 2018 The proportion of baby boomers who have been tested for hepatitis C in the United States since 2013 has increased only marginally despite a US Centers for Disease Control and Prevention (CDC) ... ← Prev1...34567...16Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive